Blair William & Co. IL lifted its holdings in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 39.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,873 shares of the company’s stock after purchasing an additional 40,231 shares during the quarter. Blair William & Co. IL owned 0.07% of Waystar worth $5,380,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of WAY. Salomon & Ludwin LLC purchased a new position in Waystar in the 3rd quarter worth approximately $25,000. ANTIPODES PARTNERS Ltd increased its holdings in shares of Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock worth $31,000 after buying an additional 449 shares during the last quarter. First Horizon Corp purchased a new stake in shares of Waystar during the 3rd quarter valued at $38,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Waystar by 3,219.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after acquiring an additional 1,352 shares during the last quarter. Finally, CWM LLC lifted its holdings in shares of Waystar by 515.8% during the 3rd quarter. CWM LLC now owns 2,100 shares of the company’s stock worth $80,000 after acquiring an additional 1,759 shares during the last quarter.
Waystar Price Performance
WAY stock opened at $24.81 on Wednesday. The firm has a market cap of $4.76 billion, a P/E ratio of 40.67, a P/E/G ratio of 1.01 and a beta of 0.80. The firm’s fifty day moving average is $27.44 and its 200 day moving average is $33.20. Waystar Holding Corp. has a 52 week low of $21.13 and a 52 week high of $42.55. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.41 and a current ratio of 1.41.
Insider Buying and Selling at Waystar
In related news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $30.08, for a total transaction of $1,209,968.00. Following the completion of the sale, the insider directly owned 474,826 shares in the company, valued at $14,282,766.08. This represents a 7.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 4.10% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on the company. Leerink Partners assumed coverage on Waystar in a research note on Monday, February 2nd. They issued an “outperform” rating and a $43.00 target price on the stock. Wall Street Zen lowered Waystar from a “buy” rating to a “hold” rating in a research note on Saturday, February 21st. Freedom Capital upgraded Waystar from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 18th. Raymond James Financial reiterated a “strong-buy” rating and set a $35.00 price objective on shares of Waystar in a research report on Thursday, March 5th. Finally, Barclays dropped their target price on Waystar from $42.00 to $36.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. Three analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $37.06.
Check Out Our Latest Report on WAY
Waystar Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Articles
- Five stocks we like better than Waystar
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding WAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waystar Holding Corp. (NASDAQ:WAY – Free Report).
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
